Terms: = Lung cancer AND ABCG2, ABC15, ABCP, BCRP, BCRP1, BMDP, CD338, CDw338, EST157481, GOUT1, MRX, MXR, MXR-1, MXR1, UAQTL1 AND Clinical Outcome
12 results:
1. A potentially functional polymorphism in abcg2 predicts clinical outcome of non-small cell lung cancer in a Chinese population.
Sun J; Zhu M; Shen W; Wang C; Dai J; Xu L; Jin G; Hu Z; Ma H; Shen H
Pharmacogenomics J; 2017 Jun; 17(3):280-285. PubMed ID: 26951883
[TBL] [Abstract] [Full Text] [Related]
2. Expression of cancer stem cell markers is more frequent in anaplastic thyroid carcinoma compared to papillary thyroid carcinoma and is related to adverse clinical outcome.
Yun JY; Kim YA; Choe JY; Min H; Lee KS; Jung Y; Oh S; Kim JE
J Clin Pathol; 2014 Feb; 67(2):125-33. PubMed ID: 23986551
[TBL] [Abstract] [Full Text] [Related]
3. Klotho predicts good clinical outcome in patients with limited-disease small cell lung cancer who received surgery.
Usuda J; Ichinose S; Ishizumi T; Ohtani K; Inoue T; Saji H; Kakihana M; Kajiwara N; Uchida O; Nomura M; Ohira T; Ikeda N
Lung Cancer; 2011 Nov; 74(2):332-7. PubMed ID: 21529984
[TBL] [Abstract] [Full Text] [Related]
4. Impact of abcg2 polymorphisms on the clinical outcome and toxicity of gefitinib in non-small-cell lung cancer patients.
Lemos C; Giovannetti E; Zucali PA; Assaraf YG; Scheffer GL; van der Straaten T; D'Incecco A; Falcone A; Guchelaar HJ; Danesi R; Santoro A; Giaccone G; Tibaldi C; Peters GJ
Pharmacogenomics; 2011 Feb; 12(2):159-70. PubMed ID: 21332310
[TBL] [Abstract] [Full Text] [Related]
5. Influence of polymorphisms on EGFR targeted therapy in non-small-cell lung cancer.
Giovannetti E; Erdem L; Olcay E; Leon LG; Peters GJ
Front Biosci (Landmark Ed); 2011 Jan; 16(1):116-30. PubMed ID: 21196162
[TBL] [Abstract] [Full Text] [Related]
6. Polymorphisms in abcg2, ABCC3 and CNT1 genes and their possible impact on chemotherapy outcome of lung cancer patients.
Müller PJ; Dally H; Klappenecker CN; Edler L; Jäger B; Gerst M; Spiegelhalder B; Tuengerthal S; Fischer JR; Drings P; Bartsch H; Risch A
Int J Cancer; 2009 Apr; 124(7):1669-74. PubMed ID: 19107936
[TBL] [Abstract] [Full Text] [Related]
7. Expression of breast cancer resistance protein is associated with a poor clinical outcome in patients with small-cell lung cancer.
Kim YH; Ishii G; Goto K; Ota S; Kubota K; Murata Y; Mishima M; Saijo N; Nishiwaki Y; Ochiai A
Lung Cancer; 2009 Jul; 65(1):105-11. PubMed ID: 19036469
[TBL] [Abstract] [Full Text] [Related]
8. Expression of multidrug resistance 1 (MDR1), multidrug resistance-related protein 1 (MRP1), lung resistance protein (LRP), and breast cancer resistance protein (bcrp) genes and clinical outcome in childhood acute lymphoblastic leukemia.
Kourti M; Vavatsi N; Gombakis N; Sidi V; Tzimagiorgis G; Papageorgiou T; Koliouskas D; Athanassiadou F
Int J Hematol; 2007 Aug; 86(2):166-73. PubMed ID: 17875533
[TBL] [Abstract] [Full Text] [Related]
9. Associations of ABCB1, ABCC2, and abcg2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer.
Han JY; Lim HS; Yoo YK; Shin ES; Park YH; Lee SY; Lee JE; Lee DH; Kim HT; Lee JS
Cancer; 2007 Jul; 110(1):138-47. PubMed ID: 17534875
[TBL] [Abstract] [Full Text] [Related]
10. Breast cancer resistance protein impacts clinical outcome in platinum-based chemotherapy for advanced non-small cell lung cancer.
Yoh K; Ishii G; Yokose T; Minegishi Y; Tsuta K; Goto K; Nishiwaki Y; Kodama T; Suga M; Ochiai A
Clin Cancer Res; 2004 Mar; 10(5):1691-7. PubMed ID: 15014021
[TBL] [Abstract] [Full Text] [Related]
11. lung resistance-related protein as a predictor of clinical outcome in advanced testicular germ-cell tumours.
Zurita AJ; Diestra JE; Condom E; García Del Muro X; Scheffer GL; Scheper RJ; Pérez J; Germà-Lluch JR; Izquierdo MA
Br J Cancer; 2003 Mar; 88(6):879-86. PubMed ID: 12644825
[TBL] [Abstract] [Full Text] [Related]
12. RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response.
Burger H; Foekens JA; Look MP; Meijer-van Gelder ME; Klijn JG; Wiemer EA; Stoter G; Nooter K
Clin Cancer Res; 2003 Feb; 9(2):827-36. PubMed ID: 12576456
[TBL] [Abstract] [Full Text] [Related]
